作者：
Giovanni,Caocci [1]
;
Marco,Vignetti [2]
;
Andrea,Patriarca [3]
;
Massimo,Breccia [4]
;
Uwe,Platzbecker [5]
;
Giuseppe A,Palumbo [6]
;
Reinhard,Stauder [7]
;
Francesco,Cottone [2]
;
Duska,Petranovic [8]
;
Maria Teresa,Voso [9]
;
Agostino,Tafuri [10]
;
Rosangela,Invernizzi [11]
;
Jo,Caers [12]
;
Mario,Luppi [13]
;
Giorgio,La Nasa [1]
;
Pasquale,Niscola [14]
;
Fabio,Efficace [15]
作者单位：
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
[1]
Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy.
[2]
Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
[3]
Department of Cellular Biotechnologies and Hematology, Division of Hematology, Sapienza University, Rome, Italy.
[4]
Clinic and Policlinic of Hematology and Cellular Therapy, Oncology and Hemostaseology, University Hospital Leipzig, Leipzig, Germany.
[5]
Dipartimento di Scienze Mediche, Chirurgiche E Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, Italy.
[6]
Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.
[7]
Department of Hematology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
[8]
Department of Biomedicine and Prevention, Università di Roma "Tor Vergata", Rome, Italy.
[9]
Azienda Ospedaliera Sant' Andrea, Rome, Italy.
[10]
Department of Internal Medicine, San Matteo IRCCS Policlinic Foundation, University of Pavia, Pavia, Italy.
[11]
Department of Hematology, CHU de Liège, University of Liege, Liege, Belgium.
[12]
Department of Medical and Surgical Sciences, Chair of Hematology, AOU Modena, University of Modena and Reggio Emilia, Modena, Italy.
[13]
Hematology Unit, Sant' Eugenio Hospital, Rome, Italy.
[14]
Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy. f.efficace@gimema.it.
[15]
DOI
10.1007/s12185-020-02920-y
PMID
32588394
发布时间
2020-10-29
换一批
换一批
